QUALITY ASSESSMENT ARTICLES
How innovation and science drive the development of EQA
EQA scheme directors Chantell Hodgson and Becky Treacy explain the complex and rigorous process that demands experience and in-depth clinical and laboratory knowledge to produce purposeful external quality assessment.
Why UK NEQAS is here – education, education, education!
Sharing knowledge is the key to more accurate laboratory testing, and also for longer-term, better patient outcomes. Scheme Directors Melody Tabiner and Richard Haggas reveal the many and varied ways in which UK NEQAS shares its expert knowledge.
Why UK NEQAS does what it does: it’s all about the patients
Dr Deborah Pritchard and Dr Gwen Wark, members of the UK NEQAS Board, explain how UK NEQAS gives users the confidence that they are providing the best results for their assays, and clinical teams and patients the reassurance that they are receiving the correct information to manage health conditions and treatment.
From COVID-19 tests to free lessons: how well do you know UK NEQAS?
Barbara De la Salle, President Elect of UK NEQAS and Dina Patel, Scientific Director for UK NEQAS Immunology, Immunochemistry and Allergy (IIA) offer a look inside UK NEQAS and how it works in practice. They share real-world examples to demonstrate who are UK NEQAS, and how the organisation delivers exceptional value to clinical and scientific stakeholders.
The challenges of creating an EQA scheme for digital pathology
UK NEQAS CPT currently has an EQA scheme for digital pathology in a pre-pilot phase. Here, Scheme Manager Lorren Mitchell details the research and planning required to ensure it will be suitable and effective for this evolving field.
Respiratory viruses point-of-care external quality assessment
External quality assessment of point-of-care testing provision is now an integral part of laboratory accreditation to the new ISO 15189 UKAS standards. Here, Sanjiv Rughooputh and colleagues from the UK Health Security Agency focus on the need for EQA of a respiratory virus POC service.
Reticulocyte haemoglobin content: a pilot UK NEQAS Haematology assessment
Reticulocyte haemoglobin content is an automated cell counting parameter that can deliver extra information with clinical utility in the investigation of iron deficiency. Here, Yvonne Hector, Barbara De la Salle and NHS colleagues in Plymouth report on a recent pilot external quality assessment exercise undertaken by UK NEQAS Haematology.
SARS-CoV-2 Point of Care: a new UK NEQAS for Microbiology EQA scheme
Point-of-care testing for the SARS-CoV-2 has expanded exponentially over the past two years, resulting in the need for an external quality assessment scheme for this activity. Here, Heather Crowton and colleagues introduce a new EQA scheme.
Latest Issues
The laboratory business is under pressure to change. Market consolidation, standardisation, advanced automation, genomic testing, and the increase in point-of-care testing are driving major shifts in where, when, and how testing takes place. To not only survive, but to thrive, laboratories need a new generation of informatics solutions with...
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
37th European Congress of Pathology
ACV, Vienna, Austria
6 -10 September, 2025